PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
11,352,650
Share change
+3,449,147
Total reported value
$8,198,997
Put/Call ratio
357%
Price per share
$0.73
Number of holders
35
Value change
+$2,476,917
Number of buys
16
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q3 2018

As of 30 Sep 2018, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,352,650 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Fosun International Ltd, Opaleye Management Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, ETF MANAGERS GROUP, LLC, SG Americas Securities, LLC, WOLVERINE ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, MEITAV DASH INVESTMENTS LTD, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 35 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.